, diabetes, smoking, cholesterol ratio, blood pressure ≥160 mmHg, HbA1c ≥65 mmol/mol, creatinine ≥100 umol/L. Median 5yr CVR was 24% (IQR 18-35%), with excellent calibration (figure) and c-statistic 0.69 (95%CI 0.677-0.698). Validation: 2,014 patients, 72% men, 92% European, median age 67yrs, with 712 CV events in the subsequent 5 years. Median predicted 5yr CVR was 32% (IQR 24-44%), with very good calibration (figure). Conclusion: A new risk score using clinical data routinely available in primary care has been developed which accurately predicts CVR among patients living in the community after an ACS event. Such models are required for risk stratification over the life-course of CV disease.

NSTEMI patients, not STEMI and UA patients, which needs to be further investigated.